VELSIPITY (etrasimod) / Pfizer

Launching a new drug class means HCPs are being asked to prescribe something they have never encountered before. As part of a broader writing team, I contributed to a launch suite that included leave behinds and HCP and patient-facing sites. My primary deliverable was the HCP Testing Guide, a document built to work across three markets simultaneously: Germany, the UK, and the US. It anticipated the questions patients would bring to their doctors and gave HCPs clear, confident language to answer them.